Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Test for Homogeneity01:23

Test for Homogeneity

The goodness–of–fit test can be used to decide whether a population fits a given distribution, but it will not suffice to decide whether two populations follow the same unknown distribution. A different test, called the test for homogeneity, can be used to conclude whether two populations have the same distribution. To calculate the test statistic for a test for homogeneity, follow the same procedure as with the test of independence. The hypotheses for the test for homogeneity can be stated as...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aurora kinase A is a synthetic lethal target in FANCA-deficient cancers.

NPJ precision oncology·2026
Same author

Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.

The Lancet. Oncology·2026
Same author

Tremelimumab with or without durvalumab in combination with paclitaxel in metastatic urothelial cancer: phase I/II ICRA trial.

Nature communications·2026
Same author

Spatiotemporal organisation of residual disease in mouse and human BRCA1-deficient mammary tumours and breast cancer.

Nature communications·2026
Same author

Nucleophagy removes cytotoxic trapped PARP1.

Nature cell biology·2026
Same author

Enabling DCIS subtyping: leveraging foundation models for robust grading and molecular biomarker scoring.

NPJ breast cancer·2026

Related Experiment Video

Updated: May 7, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

Identifying subgroup markers in heterogeneous populations.

Jorma J de Ronde1, Guillem Rigaill, Sven Rottenberg

  • 1Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands, Division of Molecular Biology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands, Division of Medical Oncology, The Netherlands Cancer Institute, 1066 CX, Amsterdam, The Netherlands and Faculty of EEMCS, Delft University of Technology, 2628 CN, Delft, The Netherlands.

Nucleic Acids Research
|September 25, 2013
PubMed
Summary

A new method, Detection of Imbalanced Differential Signal (DIDS), effectively identifies biomarkers with imbalanced patterns. DIDS outperforms traditional methods in power and predictive value for complex biological data.

More Related Videos

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations
09:34

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations

Published on: October 25, 2018

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Related Experiment Videos

Last Updated: May 7, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations
09:34

A Combinatorial Single-cell Approach to Characterize the Molecular and Immunophenotypic Heterogeneity of Human Stem and Progenitor Populations

Published on: October 25, 2018

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

Area of Science:

  • Biostatistics
  • Bioinformatics
  • Genomics

Background:

  • Traditional biomarker discovery methods assume homogeneous group behavior, failing when subgroups exhibit differential signals.
  • Imbalanced differential signals are common in biological data, necessitating specialized analytical approaches.

Purpose of the Study:

  • To introduce a novel method, Detection of Imbalanced Differential Signal (DIDS), for identifying biomarkers with imbalanced patterns.
  • To evaluate DIDS performance against traditional and existing imbalanced signal detection methods.

Main Methods:

  • Development and application of the Detection of Imbalanced Differential Signal (DIDS) algorithm.
  • Comparative analysis using artificial and human breast cancer datasets.
  • Validation on a mouse breast cancer dataset with a known chemotherapy resistance marker.

Main Results:

  • DIDS demonstrated superior performance in power and positive predictive value compared to all tested methods.
  • DIDS successfully identified a functionally validated marker of chemotherapy resistance in a mouse breast cancer model.
  • The method is applicable to continuous data, including gene expression, for detecting imbalanced differential signals.

Conclusions:

  • DIDS is a powerful and effective tool for biomarker discovery in datasets with imbalanced differential signals.
  • The method offers significant advantages over traditional approaches for complex biological data analysis.
  • DIDS has broad applicability in various research contexts involving imbalanced data patterns.